Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priti Kambli

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Indian Journal of Medical Microbiology|April 16, 2016
Multi-drug resistant tuberculous meningitisPriti Kambli, Chaitali Nikam, Anjali Shetty, et al.
The Indian Journal of Medical Research|August 29, 2025
Evaluation of the rapid lateral flow assay (LFA) for detection of five major carbapenemase enzyme families in genotypically characterised bacterial isolatesSana Rahmani, Shaoli Basu, Patricia J Simner, et al.
Indian Journal of Medical Microbiology|March 7, 2025
Unleashing the potent synergy of ceftazidime-avibactam and aztreonam against metallo-beta-lactamase producing Enterobacterales in the battle against antibiotic resistance. An in vitro studyMadhu Rai, Shaoli Basu, Priti Kambli, et al.
Indian Journal of Medical Microbiology|February 14, 2026
Plazomicin Activity against Carbapenem-Resistant Escherichia coli: A Brief ReportPriti Kambli, Shaoli Basu, Susan Rodrigues, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assayPriti Kambli, Kanchan Ajbani, Meeta Sadani, et al.
Infection and Drug Resistance|April 15, 2022
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in <i>M. tuberculosis</i> Clinical Isolates from Western and Northern IndiaVibhuti Rana, Nittu Singh, Chaitali Nikam, et al.
Tuberculosis (Edinburgh, Scotland)|January 15, 2021
Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosisPriti Kambli, Kanchan Ajbani, Mubin Kazi, et al.
Indian Journal of Medical Microbiology|July 10, 2024
Targeted Next Generation Sequencing (tNGS) for detection of drug-resistant tuberculous meningitis: Is this sequencing technology ready for prime time?Priti Kambli, Kanchan Ajbani, Amala A Andrews, et al.
Diagnostic Microbiology and Infectious Disease|March 10, 2015
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrationsPriti Kambli, Kanchan Ajbani, Meeta Sadani, et al.
International Journal of Mycobacteriology|November 17, 2016
Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6]Priti Kambli, Kanchan Ajbani, Chaitali Nikam, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Indian Journal of Medical Microbiology|April 16, 2016
Multi-drug resistant tuberculous meningitisPriti Kambli, Chaitali Nikam, Anjali Shetty, et al.
The Indian Journal of Medical Research|August 29, 2025
Evaluation of the rapid lateral flow assay (LFA) for detection of five major carbapenemase enzyme families in genotypically characterised bacterial isolatesSana Rahmani, Shaoli Basu, Patricia J Simner, et al.
Indian Journal of Medical Microbiology|March 7, 2025
Unleashing the potent synergy of ceftazidime-avibactam and aztreonam against metallo-beta-lactamase producing Enterobacterales in the battle against antibiotic resistance. An in vitro studyMadhu Rai, Shaoli Basu, Priti Kambli, et al.
Indian Journal of Medical Microbiology|February 14, 2026
Plazomicin Activity against Carbapenem-Resistant Escherichia coli: A Brief ReportPriti Kambli, Shaoli Basu, Susan Rodrigues, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assayPriti Kambli, Kanchan Ajbani, Meeta Sadani, et al.
Infection and Drug Resistance|April 15, 2022
Molecular Epidemiology and Polymorphism Analysis in Drug-Resistant Genes in <i>M. tuberculosis</i> Clinical Isolates from Western and Northern IndiaVibhuti Rana, Nittu Singh, Chaitali Nikam, et al.
Tuberculosis (Edinburgh, Scotland)|January 15, 2021
Targeted next generation sequencing directly from sputum for comprehensive genetic information on drug resistant Mycobacterium tuberculosisPriti Kambli, Kanchan Ajbani, Mubin Kazi, et al.
Indian Journal of Medical Microbiology|July 10, 2024
Targeted Next Generation Sequencing (tNGS) for detection of drug-resistant tuberculous meningitis: Is this sequencing technology ready for prime time?Priti Kambli, Kanchan Ajbani, Amala A Andrews, et al.
Diagnostic Microbiology and Infectious Disease|March 10, 2015
Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrationsPriti Kambli, Kanchan Ajbani, Meeta Sadani, et al.
International Journal of Mycobacteriology|November 17, 2016
Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6]Priti Kambli, Kanchan Ajbani, Chaitali Nikam, et al.
Pageof 2